These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7737272)

  • 21. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells.
    Ferguson AR; Youd ME; Corley RB
    Int Immunol; 2004 Oct; 16(10):1411-22. PubMed ID: 15326094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
    Schauer SL; Bellas RE; Sonenshein GE
    J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
    Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
    J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo.
    Thyphronitis G; Kinoshita T; Inoue K; Schweinle JE; Tsokos GC; Metcalf ES; Finkelman FD; Balow JE
    J Immunol; 1991 Jul; 147(1):224-30. PubMed ID: 1828822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
    Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
    J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
    J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.
    Lederman S; Yellin MJ; Cleary AM; Pernis A; Inghirami G; Cohn LE; Covey LR; Lee JJ; Rothman P; Chess L
    J Immunol; 1994 Mar; 152(5):2163-71. PubMed ID: 7907632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells.
    Foote LC; Schneider TJ; Fischer GM; Wang JK; Rasmussen B; Campbell KA; Lynch DH; Ju ST; Marshak-Rothstein A; Rothstein TL
    J Immunol; 1996 Sep; 157(5):1878-85. PubMed ID: 8757305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice.
    Yellen AJ; Glenn W; Sukhatme VP; Cao XM; Monroe JG
    J Immunol; 1991 Mar; 146(5):1446-54. PubMed ID: 1847161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A spatial association between membrane IgD and the receptor for C3b (CR1) at the cell surface of murine B lymphocytes.
    Sitia R; Rabellino EM; Sockell M; Hämmerling U
    J Immunol; 1981 Jan; 126(1):107-12. PubMed ID: 7005331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genesis of B lymphocytes in the bone marrow: extravascular and intravascular localization of surface IgM-bearing cells in mouse bone marrow detected by electron-microscope radioautography after in vivo perfusion of 125I anti-IgM antibody.
    Osmond DG; Batten SJ
    Am J Anat; 1984 Jul; 170(3):349-65. PubMed ID: 6383003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.
    Carter RH; Fearon DT
    J Immunol; 1989 Sep; 143(6):1755-60. PubMed ID: 2528579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal regulation of mucosal surface IgA+ B cells by Ig receptor cross-linking and CD40 ligand.
    Ehrhardt RO; Gray B; Duchmann R; Inman JK; Strober W
    J Immunol; 1996 Aug; 157(4):1397-405. PubMed ID: 8759719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.